[{"NetIncomeLoss_1_Q3_USD":-26811000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":381000.0,"AssetsCurrent_0_Q3_USD":256929000.0,"OperatingLeaseExpense_3_Q3_USD":280000.0,"OperatingLeaseExpense_1_Q3_USD":85000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":4152000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":105000.0,"DueToRelatedPartiesCurrent_0_Q3_USD":154000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":372000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-433000.0,"CommonStockSharesIssued_0_Q3_shares":27980000.0,"ShareBasedCompensation_3_Q3_USD":17219000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":1312000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":100993000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":193000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":391000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":1739000.0,"Assets_0_Q3_USD":261332000.0,"CommonStockSharesAuthorized_0_Q3_shares":100000000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":10716000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"ResearchAndDevelopmentExpense_3_Q3_USD":40183000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":11933000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":1660000.0,"CommonStockValue_0_Q3_USD":28000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":2807000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":221000.0,"DepreciationDepletionAndAmortization_1_Q3_USD":76000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":102447000.0,"GainLossOnSaleOfPropertyPlantEquipment_3_Q3_USD":-46000.0,"OtherAssetsNoncurrent_0_Q3_USD":1755000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":1180000.0,"Liabilities_0_Q3_USD":15776000.0,"OperatingLeaseLiability_0_Q3_USD":1467000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"GeneralAndAdministrativeExpense_3_Q3_USD":40621000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":14879000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":25832000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":27972000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":252912000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":89000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":null,"OperatingIncomeLoss_3_Q3_USD":-80804000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":526000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":4885000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-62221000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":363000.0,"LiabilitiesCurrent_0_Q3_USD":14596000.0,"AccountsPayableCurrent_0_Q3_USD":3439000.0,"InterestExpense_3_Q3_USD":34000.0,"InterestExpense_1_Q3_USD":11000.0,"CommonStockSharesOutstanding_0_Q3_shares":27980000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":252912000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":1454000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":140000.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1_Q3_USD":34000.0,"AdditionalPaidInCapital_0_Q3_USD":465191000.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":1336000.0,"NetIncomeLoss_3_Q3_USD":-80806000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":4017000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":39793000.0,"TaxesPayableCurrent_0_Q3_USD":199000.0,"OperatingIncomeLoss_1_Q3_USD":-26812000.0,"InvestmentIncomeInterest_3_Q3_USD":32000.0,"InvestmentIncomeInterest_1_Q3_USD":12000.0,"PreferredStockValue_0_Q3_USD":null,"LiabilitiesAndStockholdersEquity_0_Q3_USD":261332000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":3495000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":17219000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-219663000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":4886000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":287000.0,"OperatingExpenses_3_Q3_USD":80804000.0,"OperatingExpenses_1_Q3_USD":26812000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-3.13,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.96,"OtherLiabilitiesCurrent_0_Q3_USD":287000.0,"StockholdersEquity_0_Q3_USD":245556000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":433000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":1862000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":2188000.0,"Ticker":"BTAI","CIK":"1720893","name":"BIOXCEL THERAPEUTICS, INC.","OfficialName":"BioXcel Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"417746551.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211110"}]